P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS

ABSTRACT:

SUBMITTER: Min Byun J 

PROVIDER: S-EPMC10431110 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature